𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort

✍ Scribed by Essig, Stefan; Li, Qiaozhi; Chen, Yan; Hitzler, Johann; Leisenring, Wendy; Greenberg, Mark; Sklar, Charles; Hudson, Melissa M; Armstrong, Gregory T; Krull, Kevin R; Neglia, Joseph P; Oeffinger, Kevin C; Robison, Leslie L; Kuehni, Claudia E; Yasui, Yutaka; Nathan, Paul C

Book ID
125803810
Publisher
The Lancet
Year
2014
Tongue
English
Weight
184 KB
Volume
15
Category
Article
ISSN
1470-2045

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of high-risk acute lymphoblast
Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: A report from the Kyushu-Yamaguchi children cancer study group in Japan
✍ Matsuzaki, Akinobu; Ishii, Eiichi; Okamura, Jun; Eguchi, Haruhiko; Yoshida, Nobu πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 770 KB

A total of 125 children, who were diagnosed as having high-risk acute lymphoblastic leukemia (ALL), were treated with two consecutive protocols designated as AL851 (1985( -1988( ) and ALHR88 (1988( -1990)). All patients received induction therapy consisting of vincristine (VCR), prednisolone (PSL),